
Pfizer/BioNTech says a three-dose regimen of its COVID-19 vaccine appears to provoke a strong immune response in the youngest age group of children — those aged 6 months to 5 years. This is the only age group not yet approved for COVID-19 vaccination by the U.S. Food and Drug Administration. According to CNN, Pfizer said… read on > read on >